Cenra (3716.TW) Stock Price

Cenra Price

CLOSED
34.15
​
Market closed

Over the last 19 years Cenra grew revenue by 4.7% annually, reaching 8.57 B TWD. Earnings per share have grown at 4.7% per year over the last 19 years. For Cenra, the net margin of 3.5% is down versus 6.5% a few years ago. At today's price the dividend yield works out to roughly 2.98%. The payout ratio is around 50% of earnings.

Cenra stock price

Access this data via the Eulerpool API

Cenra business model & stock analysis

Cenra Inc is a TW-based company operating in Pharmaceuticals industry. The company is headquartered in Taipei City, Taipei. The company went IPO on 2024-09-02. Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products and the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and other lotion products, skin care series and other.

Frequently asked questions about Cenra

Converted at the current exchange rate, the Cenra share trades at 0.95 EUR (34.15 TWD).

The revenue cannot currently be calculated for Cenra.

The profit cannot currently be calculated for Cenra.

The P/E ratio cannot be calculated for Cenra at the moment.

The P/S cannot be calculated for Cenra currently.

The Eulerpool Quality Score for Cenra is 5/10.

The ISIN of Cenra is TW0003716007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cenra is 3716.TW. The ticker symbol is used to trade Cenra shares on the stock exchange.

Fair ValueTerminal
28.34 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Taiwan
Currency
TWD
Initial public offering
Sep 2, 2024
ISIN
TW0003716007
Cusip
Y1R49U108
Market capitalization
5.11 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
10.80
P/B Ratio
0.68
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.84 %
Dividend
Dividend yield
2.98 %
Payout Ratio
49.53 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
21.00 %
Last updated Oct 11, 2026, 6:47 PM

Cenra Peer Group

All fundamentals and in-depth analysis of Cenra

Our stock analysis for Cenra stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cenra. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.